ID
44586
Beschreibung
Study ID: 111364 Clinical Study ID: 111364 Study Title: A 28-Day, Polysomnographic and subjective assessment of Vestipitant (15mg/day) for the treatment of Primary Insomnia in adult Outpatients Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00992160 Clinicaltrials.gov Links: https://clinicaltrials.gov/ct2/show/NCT00992160 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Vestipitant, Placebo Trade Name: N/A Study Indication: Primary Insomnia, Sleep Disorders This phase II, placebo-controlled, double-blind trial studies the polysomnographic and subjective effect of the neurokinin (NK1) antagonist vestipitant (15mg/day at bedtime) for the treatment of primary insomnia in adult outpatients over a period of four weeks. The study consists of a clinical Screening Visit (Visit 1), up to 21 days before investigational product/placebo initiation, two screening polysomnographies (Visits 2 and 3), followed by a placebo run-in until Visit 4, at which the subject is randomized to vestipitant or placebo, taken every night for 28 days. On Day 1 and 2 (Visits 4 and 5), polysomnographies are performed. Visit 6 is a safety visit on Day 15. On Day 27 and 28, Visits 7 and 8 are performed, which again include polysomnography studies. Subjects then undergo a 7 to 10 day placebo run-out period and have Day 7 and Day 14 Follow-Up Visit (Visits 9 and 10). The purpose of this form is to record the results of unscheduled vital sign measurements. There is a seperate form for scheduled measurements. All vital signs should be taken in a sitting position.
Link
https://clinicaltrials.gov/ct2/show/NCT00992160
Stichworte
Versionen (2)
- 10.11.19 10.11.19 -
- 27.09.21 27.09.21 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
27. September 2021
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Polysomnographic Assessment of Vestipitant for the Treatment of Primary Insomnia NCT00992160
Logs/Repeats Vital Signs
- StudyEvent: ODM
Beschreibung
Vital Signs
Alias
- UMLS CUI-1
- C0518766
Beschreibung
Vital Signs Date/Time
Datentyp
datetime
Alias
- UMLS CUI [1,1]
- C1264639
- UMLS CUI [1,2]
- C0518766
Beschreibung
If done, record systolic/diastolic value in next items.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0005824
- UMLS CUI [1,2]
- C1272696
Beschreibung
Blood pressure Systolic
Datentyp
integer
Maßeinheiten
- mmHg
Alias
- UMLS CUI [1]
- C0871470
Beschreibung
Blood pressure Diastolic
Datentyp
integer
Maßeinheiten
- mmHg
Alias
- UMLS CUI [1]
- C0428883
Beschreibung
If done, record result in next item.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0018810
- UMLS CUI [1,2]
- C1272696
Beschreibung
Heart rate
Datentyp
integer
Maßeinheiten
- beats/min
Alias
- UMLS CUI [1]
- C0018810
Beschreibung
If done, record result in next item.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0231832
- UMLS CUI [1,2]
- C3841220
Beschreibung
Respiration rate
Datentyp
integer
Maßeinheiten
- breaths/min
Alias
- UMLS CUI [1]
- C0231832
Beschreibung
If done, record result in next item.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0886414
- UMLS CUI [1,2]
- C1272696
Beschreibung
Temperature
Datentyp
float
Maßeinheiten
- °C
Alias
- UMLS CUI [1]
- C0005903
Ähnliche Modelle
Logs/Repeats Vital Signs
- StudyEvent: ODM
C2985720 (UMLS CUI [2])
C0518766 (UMLS CUI [1,2])
C1272696 (UMLS CUI [1,2])
C1272696 (UMLS CUI [1,2])
C3841220 (UMLS CUI [1,2])
C1272696 (UMLS CUI [1,2])